Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Medulloblastoma × Metformin × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 9 Obesity 3 Melanoma 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Infertility 2 Glioblastoma 2 Adenocarcinoma Of Esophagus 2 TP53 Y220C Mutation 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Prostate Cancer Recurrent 1 Progression-Free Survival 1 Preleukemia 1 Posterior Fossa Ependymal Tumor 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Metabolic Diseases 1 Medulloblastoma 1 Leukoplakia, Oral 1 Leukemia, Myeloid, Acute 1 Insulin Resistance 1 Hyperandrogenism 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1

Interventions

Temozolomide 5 Cyclophosphamide 5 Etoposide 4 Radiotherapy 3 lutetium Lu 177 dotatate 2 Vincristine 2 Radiation 2 Cisplatin 2 sodium thiosulfate 1 pegfilgrastim 1 olaparib 1 ibrutinib 1 fludarabine 1 fenofibric acid 1 etoposide phosphate 1 Topotecan 1 Thalidomide 1 Tablets 1 Standard of Care 1 Specimen Handling 1 Platinum 1 ONC206 1 Methotrexate 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Lomustine 1 Irinotecan 1 Hearing 1 Filgrastim 1 Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05230758 2026-01-22

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡